SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000059478-19-000322
Filing Date
2019-12-17
Accepted
2019-12-17 08:46:42
Documents
16
Period of Report
2019-12-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k2020guidancedecemb.htm   iXBRL 8-K 58837
2 EXHIBIT 99.1 lilly2020financialguid.htm EX-99.1 91142
8 lilly2020financialgui_image1.gif GRAPHIC 6521
  Complete submission text file 0000059478-19-000322.txt   394373

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20191217.xsd EX-101.SCH 6146
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20191217_cal.xml EX-101.CAL 613
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20191217_def.xml EX-101.DEF 17991
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20191217_lab.xml EX-101.LAB 41802
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20191217_pre.xml EX-101.PRE 20268
14 EXTRACTED XBRL INSTANCE DOCUMENT a8-k2020guidancedecemb_htm.xml XML 13397
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 191288646
SIC: 2834 Pharmaceutical Preparations